Commitment 1 CSR Report 2025
Commitment 1 CSR Report 2025
Acting to advance better-supported health, grounded in science and appropriate use
Access through pharmacies: a commitment to appropriate use
Exclusive distribution through pharmacies is a strategic choice, not a regulatory constraint. It reflects a conviction: a health solution only makes sense if it is recommended by a healthcare professional and integrated into a genuine care pathway. Without such structured advice, the chosen solution risks proving entirely ineffective, or even unsuitable.
It guarantees the right care, at the right time, in the right place. It is also why we build lasting relationships with healthcare professionals, based on trust, dialogue and transparency.
This standard shapes all our communications. Claims govern our exchanges with healthcare professionals, in strict compliance with Regulation( EC) No 1924 / 2006. Every scientific publication or presentation systematically names PiLeJe as funder or co-funder, so that every healthcare professional can assess our work with full knowledge of the facts.
In ten years ' time, our sector will not be judged on what it has sold, but on what it has proven. On the strength of its evidence, the quality of its dialogue with healthcare professionals, and the medical trust it has regained. On its courage to move the regulatory framework forward, and on the maturity of a communication that does not give in to the noise.
Pascaline Gervoson Chief Executive Officer
22